ALK-Abelló A/S
ALK-B
Rang în acțiuni
#2433
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Preț acțiune
$36.23
Ultima sincronizare: 2026-10-16
Capitalizare de piață
$8.04B
Schimbare (1 zi)
-1.72%
Schimbare (1 an)
12.00%
Țară
DK
Tranzacționează ALK-Abelló A/S (ALK-B)
Categorie
Healthcare
Capitalizarea de piață a ALK-Abelló A/S(ALK-B)
Capitalizare de piață: $8.04B
În anul October 2026, ALK-Abelló A/S are o capitalizare de piață de $8.04B. Acest lucru face ca ALK-Abelló A/S să fie a 2433rd-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a ALK-Abelló A/S din 2009 până în 2026
ALK-B în comparație cu top 5 cele mai populare stocks
